Co-Diagnostics (CODX) Projected to Post Earnings on Thursday

Co-Diagnostics (NASDAQ:CODX) is expected to be posting its quarterly earnings results before the market opens on Thursday, March 27th. Analysts expect Co-Diagnostics to post earnings of ($0.34) per share and revenue of $0.38 million for the quarter.

Co-Diagnostics Stock Performance

NASDAQ:CODX opened at $0.47 on Thursday. The company has a fifty day moving average of $0.66 and a two-hundred day moving average of $0.93. The stock has a market capitalization of $15.15 million, a PE ratio of -0.34 and a beta of 1.29. Co-Diagnostics has a fifty-two week low of $0.43 and a fifty-two week high of $2.23.

Co-Diagnostics Company Profile

Co-Diagnostics, Inc, a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting.